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Deregulation of Cdk5 in a Mouse Model of ALS:
Toxicity Alleviated by Perikaryal
Neurofilament Inclusions
been observed in ALS patients (Carpenter, 1968; Hirano
et al., 1984; Schmidt et al., 1987; Rouleau et al., 1996)
and in mice overexpressing ALS-linked SOD1 mutants
(Wong et al., 1995; Bruijn et al., 1997). It remains un-
known to what extent NF abnormalities contribute to
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the pathogenesis of human ALS, but recent transgenicHealth Centre
mouse studies suggest that an axonal localization ofMontre´al, Que´bec, H3G 1A4
intermediate filament aggregates may be an importantCanada
factor of toxicity (Williamson et al., 1998; Beaulieu et al.,
1999; Beaulieu et al., 2000). The overexpression in mice
of wild-type NF subunits can provoke ALS-like NF accu-Summary
mulations in the perikaryon of motor neurons, axonal
atrophy, and sometimes motor dysfunction caused byRecent studies suggest that increased activity of
altered ionic conductances, but it does not cause mas-cyclin-dependent kinase 5 (Cdk5) may contribute to
sive motor neuron death (for review, see Julien, 1999).neuronal death and cytoskeletal abnormalities in Alz-
Remarkably, the overexpression of human NF heavyheimer’s disease. We report here such deregulation
subunits (NF-H) increased by up to 65% the life spanof Cdk5 activity associated with the hyperphosphory-
of mice expressing SOD1G37R, suggesting a protectivelation of tau and neurofilament (NF) proteins in mice
effect of perikaryal accumulations of NF proteins (Couil-expressing a mutant superoxide dismutase (SOD1G37R)
lard-Despre´s et al., 1998). The NF-H protein is a highlylinked to amyotrophic lateral sclerosis (ALS). A Cdk5
phosphorylated protein, and its KSP (Lys-Ser-Pro) re-involvement in motor neuron degeneration is sup-
peat-enriched tail domain constitutes a target for severalported by our analysis of three SOD1G37R mouse lines
protein kinases, including stress-activated protein ki-exhibiting perikaryal inclusions of NF proteins. Our
nase-g (SAPK-g) (Giasson and Mushynski,1996), extra-results suggest that perikaryal accumulations of NF
cellular signal regulated kinases (ERK 1/2) (Veeranna etproteins in motor neurons may alleviate ALS patho-
al., 1998), glycogen synthase kinase 3 (GSK-3) (Guidatogenesis by acting as a phosphorylation sink for Cdk5
et al., 1996; Bajaj and Miller, 1997), and cyclin-depen-activity, thereby reducing the detrimental hyperphos-
dent kinase 5 (Cdk5), a serine/threonine kinase withphorylation of tau and other neuronal substrates.
close structural homology to the mitotic cyclin-depen-
dent kinases (Cdk) (Guidato et al., 1996; Bajaj and Miller,Introduction
1997; Bajaj et al., 1999).
Activation of Cdk5 requires critical association withAmyotrophic lateral sclerosis (ALS) is an adult-onset
its neuron-specific regulatory subunit p35 (Tsai et al.,neurological disorder characterized by the selective de-
1994). The p35/Cdk5 complex is essential for centralgeneration of motor neurons leading to paralysis and
nervous system development and mainly for neurite out-death within 3–5 years (for review, see Cleveland, 1999;
growth (Tsai et al., 1993; Nikolic et al., 1996; Oshima etJulien, 2001). Missense mutations in the gene coding
al., 1996; Kwon and Tsai, 1998). In addition to NF-H, thefor the Cu/Zn superoxide dismutase 1 (SOD1), located
substrates for Cdk5 include the microtubule-associatedon chromosome 21, account for z20% cases of familial
protein tau, Munc-18, DARPP-32, the RetinoblastomaALS (Rosen et al., 1993; Cudkowicz et al., 1997). The
protein, PAK1, Synapsin 1, c-src, and APC (Mandelkow,
SOD1 protein is a cytosolic metalloenzyme catalyzing
1999). The abnormal subcellular localization of Cdk5 has
the conversion of superoxide anions to hydrogen perox-
been observed in several neurodegenerative diseases,
ide (Fridovich, 1986). Transgenic mice expressing mu- including ALS (Bajaj et al., 1998), Alzheimer’s disease
tant SOD1 develop motor neuron disease resembling (Yamaguchi et al., 1996; Pei et al., 1998), Parkinson’s
ALS through a gain of unidentified deleterious properties disease (Brion and Couck, 1995), as well as canine motor
(Wong et al., 1995; Bruijn et al., 1997, Bruijn et al., 1998). neuron disease (Green et al., 1998). Moreover, recent
Several mechanisms have been proposed to account studies suggest that a deregulation of Cdk5 activity may
for such toxicity, including excitotoxicity (Bruijn et al., directly contribute to pathogenesis. Patrick et al. (1999)
1997; Trotti et al., 1998), oxidation/nitration-related dam- reported the accumulation of p25, a truncated form of
age (Beckman et al., 1993; Wideau-Pazos et al., 1996), p35, in the brains of patients with Alzheimer’s disease.
disruption of the calcium homeostasis (Morrison et al., Their results show that p25, which is not targeted to the
1996; Roy et al., 1998), copper toxicity (Corson et al., plasma membrane like p35, sequesters Cdk5 away from
1998), apoptosis mediated by caspases activation (Pasi- normal compartments of p35/Cdk5 and deregulates its
nelli et al., 1998; Li et al., 2000), and zinc deficiency activity. Expression of the p25/Cdk5 complex in cultured
(Estevez et al., 1999). cortical neurons induced cytoskeletal abnormalities and
Abnormal accumulations of neurofilaments (NFs) in apoptosis (Patrick et al., 1999; Lee et al., 2000). More-
the perikaryon or axon of spinal motor neurons have over, the overexpression of p25 in the CNS of transgenic
mice caused hyperphosphorylation of tau and NFs, cy-
toskeletal disruption, and behavioral deficits (Ahlijanian* To whom correspondence should be addressed (e-mail: mdju@
musica.mcgill.ca). et al., 2000).
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Figure 1. P25-Dependent Mislocalization and Deregulation of Cdk5 in Spinal Motor Neurons of SOD1G37R Mice
(A) Immunoreactivity for Cdk5 occurs at the cell membrane and in the cell body and nucleus of spinal motor neurons in ventral horn of SOD1G37R
mice (G37R) (second panel, white arrowheads, and last three panels, white arrows), whereas Cdk5 immunostaining in spinal motor neurons
of normal mice (WT) is extensively reduced (first panel). Bars, 20 mm (two upper panels) and 15 mm (three lower panels).
(B) Western blots of total extracts (lanes 1 to 4) or soluble extracts (lanes 5 and 6) of spinal cord from SOD1G37R and normal mice with an
antibody recognizing both p25 and p35 (C-19) revealed an increased p25/p35 ratio in SOD1G37R mice as compared with normal mice. The blots
were stripped and incubated with anti-actin antibodies. The levels of the protein are similar in the different samples. Quantitative analysis by
densitometry with the C-19 antibodies showed elevated p25/p35 ratios (up to 70%) in SOD1G37R mice, whereas it is of z20% in normal mice.
(C) Western blots of soluble extracts of spinal cord from normal and SOD1G37R mice with an antibody recognizing p25 (N-23) show enhanced
levels of p25 protein level in SOD1G37R mice as compared with normal mice. The N-23 antibodies recognizing specifically the N terminus of
p25 but not p35 yielded very poor p25 signal in samples from normal mice (WT) in contrast to samples from SOD1G37R mice.
(D) Immunohistochemical staining with N-23 antibodies confirmed the presence of p25 in motor neurons of SOD1G37R mice (white arrowheads).
Bar, 20 mm.
(E) Western blots with two Cdk5 antibodies (C-8 and J-3) reveal unchanged levels of the Cdk5 kinase in SOD1G37R mice despite its mislocalization
in spinal motor neurons. The specificity of C-8 antibodies was confirmed with the preincubation of antibodies with a Cdk5 peptide.
(F) Kinase assays performed after immunoprecipitation of spinal cord extracts with Cdk5 antibodies showed a 2-fold increase in total specific
kinase activity of Cdk5 from the spinal cord of SOD1G37R mice. Autoradiogram showing the quantity of 32P incorporated in histone H1 from
Cdk5 in spinal cord extracts of normal and SOD1G37R mice (upper panel). The lower panel shows the immunodetection of Cdk5. The histograms
show the quantification of 32P after correction for Cdk5 protein levels. All immunohistochemistry, Western blot, and kinase assay experiments
were carried out with 8- to 12-month-old SOD1G37R mice and age-matched normal littermates.
We report here that the p25/p35 ratio and Cdk5 activity thereby reducing the noxious hyperphosphorylation of
tau and other cellular substrates.are abnormally elevated in the spinal cord of transgenic
mice expressing SOD1G37R and that this is associated
with the hyperphosphorylation of NF and tau proteins. Results
There was a slowing down of disease in three SOD1G37R
mouse lines exhibiting abnormal accumulations of NF High p25/p35 Ratio and Deregulated Cdk5
Activity in SOD1G37R Miceproteins in perikarya of motor neurons. We propose that
perikaryal NF accumulations may act as a phosphoryla- To investigate the potential involvement of kinases in
disease caused by mutant SOD1, we have comparedtion sink for deregulated Cdk5 activity in ALS mice,
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by immunohistochemistry the distribution of various ki-
nases in the spinal cord of SOD1G37R mice (line 29) and
of normal mice. Phospho-dependent antibodies recog-
nizing activated or inactivated forms of MEK1/2, Erk1/
2, JNK, p38, Gsk-3b, and p70S6K did not reveal major
immunostaining differences in spinal motor neurons be-
tween SOD1G37R mice and normal mice (data not shown).
However, activated forms of Erk1/2, p38, and p70S6K
were detected in glial cells of SOD1G37R mice (data not
shown). In contrast, a striking difference was observed
in the immunostaining of motor neurons with antibodies
against Cdk5. In normal mice, anti-Cdk5 antibodies
yielded very poor immunoreactivity in the cell body of
spinal motor neurons (Figure 1A, upper panel), whereas
an intense Cdk5 immunostaining was observed in spinal
motor neurons of SOD1G37R mice (Figure 1A, second
panel, white arrowheads). Moreover, whereas Cdk5 is
normally targeted to the cell membrane (Patrick et al.,
1999), the Cdk5 in SOD1G37R mice was detected in the
cytoplasm and nucleus of motor neurons (Figure 1A,
last three panels, white arrows). Such mislocalization of
Cdk5 in neurons has been previously attributed to the
conversion of p35 to p25, which lacks the conserved
myristoylation sequence of p35 (Patrick et al., 1999).
Using an antibody (C-19) recognizing both the p25
and p35 fragments, we have determined by Western
blotting the p25 and p35 levels in spinal cord extracts
from normal mice and from SOD1G37R mice (Figure 1B).
The p25/p35 ratio in total spinal cord extracts from
SOD1G37R mice was higher than those from normal mouse
littermates (Figure 1B, lanes 1–4). The increase of p25/
p35 ratio in SOD1G37R mice was even more pronounced
in soluble spinal cord extracts (Figures 1B, lanes 5 and
6). Quantitative analysis of the band signals from the
soluble fraction using the ImageQuant and Gel Pro Ana-
lyzer software revealed a 3-fold increase of p25/p35 ratio
in SOD1G37R mice as compared with normal littermates
(Figure 1B). The increase of p25 protein levels in SOD1G37R
mice was further confirmed by Western blots with an
antibody recognizing specifically the N terminus of p25
but not p35 (Figure 1C). Immunostaining of spinal cord
sections from SOD1G37R mice with an anti-p25 N-terminal
antibody further confirmed the presence of p25 in spinal
motor neurons (Figure 1D). These results suggest that
p25 is likely responsible for the mislocalization of Cdk5
in motor neurons of SOD1G37R mice. Note that in spite
of its mislocalization, the levels of Cdk5 protein in the
spinal cord of SOD1G37R mice remained similar to those
in normal mice, as revealed by immunoblotting with poly-
clonal C-8 and monoclonal J-3 antibodies (Figure 1E).
Preincubation of C-8 antibodies with a Cdk5 blocking
peptide abolished the immunoreactivity for Cdk5. To
determine whether the high p25/p35 ratio was associ-
Figure 2. Hyperphosphorylation of Tau and NF Proteins in Motor
ated with enhanced Cdk5 kinase activity, Cdk5 was im-Neurons of SOD1G37R Mice
(A) A Western blot of spinal cord extracts shows the hyperphosphor-
ylation of tau at Cdk5 sites (serines 199 and 202).
(D) A Western blot of spinal cord extracts shows the hyperphosphor-(B) Immunohistochemical staining with the monoclonal antibody AT-8
confirmed that tau is hyperphosphorylated in some motor neurons ylation of tau at Cdk5 sites in SOD1G37R mice (lanes 3 and 4), as
revealed by the reduced Tau 1 immunoreactivities as comparedof SOD1G37R mice (white arrow). Note that not all motor neurons
exhibited an AT8-positive signal (black arrow). Bar, 15 mm. with extracts of normal mice (lanes 1 and 2).
(E) Immunohistochemistry demonstrates the abnormal hyperphos-(C) A Western blot of spinal cord extracts shows the hyperphosphor-
ylation of tau at one other Cdk5 site (serine 396) in SOD1G37R mice phorylation of NF-M and NF-H proteins in the neuronal perikarya of
SOD1G37R mice. The black arrowheads point to cell bodies in the(G37R) (lanes 3 and 4) as revealed by PHF-1 immunoreactivity, unlike
extracts from normal mice (WT) (lanes 1 and 2). spinal cord of normal mice. Bar, 10 mm.
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munoprecipitated with anti-Cdk5 antibodies from spinal
cord lysates (250 mg) followed by a kinase assay using
histone H1 as exogenous substrate. Figure 1F (upper
gel) shows an autoradiogram of 32P-labeled histone H1
using Cdk5 from spinal cord extracts of normal and
SOD1G37R mice. The lower panel in figure 1F shows the
detection of immunoprecipitated Cdk5 with C-8 anti-
bodies. Quantification of radioactivity incorporated in
histone H1 was performed by phosphoimager and ad-
justed to the level of Cdk5 immunoprecipitated. Our
analysis revealed a 2-fold increase of specific Cdk5 ki-
nase activity in lysates of SOD1G37R mice (8–12 months
old) as compared with age-matched normal littermates
(histogram in Figure 1F).
Hyperphosphorylation of Tau and NF Proteins
in SOD1G37R Mice
We then examined whether the increased Cdk5 activity
in SOD1G37R mice was associated with hyperphosphory-
lation of Cdk5 cytoskeletal substrates such as tau and
NF proteins. We used the AT-8 and PHF-1 antibodies
that recognize three phosphoserines (199, 202 for AT-8,
and 396 for PHF-1) in the tau protein that can be phos-
phorylated by Cdk5. The hyperphosphorylation of these
sites has been associated with Alzheimer’s disease (Ya-
maguchi et al., 1996; Pei et al., 1998). Spinal cord ex-
tracts from SOD1G37R mice and normal mice were frac-
tionated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) followed by immunoblot-
ting with AT-8 or PHF-1 antibodies. No AT-8 and PHF-1
immunoreactivities were detected in samples from nor-
mal mice (Figure 2A, lanes 1 and 2, and 2C, lanes 1 and
2). However, in extracts from SOD1G37R mice, the AT-8
and PHF-1 antibodies recognized 52–55 kDa species of
tau and to a lower extent the 68 kDa species, indicating
a hyperphosphorylation of tau in these extracts (Figure
2A, lanes 3 and 4, and 2C, lanes 3 and 4). Alkaline
phosphatase treatment of the blot completely abolished
the AT-8 and PHF-1 signals for the SOD1G37R samples,
Figure 3. Perikaryal Accumulations of NF Proteins in SOD1G37R Mice confirming that the immunoreactivity reflected tau hy-
Lacking NF-L perphosphorylation state (data shown later in this arti-
(A) NF and SOD1 protein expression in mice knockout for NF-H cle). We have also tested the Tau 1 antibody that recog-
or NF-L genes. Western blot analysis of spinal cord extracts from
nizes a dephosphorylated epitope of tau at amino acids7-month-old mice confirms the absence of NF-H and NF-L in mice
191–224 (Iqbal and Grunke-Iqbal, 1995). This epitopewith disrupted NF-H or NF-L genes, respectively. The RT-97 and
includes three Cdk5 recognition sites (Ser 199, Ser 202,NR-4 antibodies were used for the immunodetection of NF-H and
NF-L, respectively. No changes in levels of NF-L protein occurred and Thr 205) (Baumann et al., 1993; Lew et al., 1995).
in NF-H null mice (H2/2 and G37R;H2/2 mice), whereas a 90% reduc- In extracts from normal mice, the Tau 1 antibodies rec-
tion of NF-H and NF-M protein levels occurred in NF-L null mice ognized hypophosphorylated species of tau, including
(L2/2 and G37R;L2/2) mice. The lack of NF-H or NF-L did not affect
52–55 kDa, 68 kDa, and 100 kDa bands (Figure 2D, laneslevels of endogenous wild-type (mSOD1) or human SOD1G37R pro-
1 and 2). The signal intensity for Tau 1 immunoreactivityteins.
was considerably reduced in samples from the SOD1G37R(B) Transverse sections of L5 ventral roots and spinal cord from
SOD1G37R mice, SOD1G37R lacking NF-H (G37R;H2/2), and SOD1G37R mice (Figure 2D, lanes 3 and 4), confirming an hyper-
mice lacking NF-L (G37R;L2/2). All mice were at 4 months old at a phosphorylation of tau in these extracts. As expected,
stage in which there are no signs of degeneration. The lack of NF-H the Tau 1 signal in SOD1G37R samples was restored by
had few effects on the radial growth of motor axons, whereas the
alkaline phosphatase treatment of the blots (data shownabsence of NF-L resulted in a dramatic decrease of axonal caliber.
later in this article; Figure 6). These combined resultsMoreover, the SOD1G37R mice lacking NF-L exhibited accumulations
with the three anti-tau antibodies indicate that tau isin the perikaryon of spinal motor neurons (white arrowheads), unlike
spinal motor neurons of SOD1G37R mice with a normal NF background hyperphosphorylated in spinal cord of SOD1G37R mice.
(white arrowheads) or lacking NF-H (white arrowheads). Bars, 7 mm
(left panel) and 25 mm (right panel).
(C) Immunodetection of NF proteins in neuronal perikarya of
SOD1G37R mice lacking NF-L. Immunostaining of spinal cord sections phorylated NF-H and NF-M, respectively. This staining indicates
from G37R;L2/2 mice revealed intense SMI 31 and NN-18 immunore- that perikaryal inclusions in spinal motor neurons of G37R;L2/2 mice
activities (white arrowheads). These antibodies recognize phos- are made up with phosphorylated NF-H and NF-M. Bar, 30 mm.
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Table 1. Lifespan of SOD1G37R Mice (lines 29 and 42) with Altered NF Background
Genotype Average Lifespan (Weeks) Median of Life Probability (Weeks)*
No perikaryal NF swellings
SOD1G37R (line 29) (n540) 51.8 6 2.1 52.5
SOD1G37R (line 29);H2/2 (n515) 50.5 6 2.0 52.0
SOD1G37R (line 42) (n520) 23.6 6 1.5 24.0
With perikaryal NF swellings
SOD1G37R (line 29);L2/2 (n525) 62.3 6 5.3 62.8
SOD1G37R (line 29);hNF-H43 (n512) 66.0 6 5.5 68.0
SOD1G37R (line 42);hNF-H43 (n57) 24.3 6 2.2 25.0
* The median of life probability is defined as the age at which the probability of survival is 50%.
In addition, the AT-8 antibodies were used for immuno- an accumulation of these unassembled NF subunits was
detected in the perikaryon of motor neurons (Figureshistochemical staining to confirm the presence of hyper-
phosphorylated tau in spinal motor neurons of SOD1G37R. 3B and 3C). NF-L is a requirement for the IF assembly
and for the efficient transport of newly synthesized NF-MAt the end stage of disease in SOD1G37R mice, some
motor neurons (20%) in L5 spinal cord sections exhib- or NF-H proteins (for review, see Lee and Cleveland,
1996; Julien, 1999).ited intense staining with the AT-8 antibody (Figure 2B,
right panel). In contrast, motor neurons from normal The knockout of NF-H gene did not provoke perikaryal
accumulations, and it had no effects on the longevitymice were poorly stained with the AT-8 antibody (Figure
2B, left panel). The NF-H and NF-M proteins were also of SOD1G37R (Table 1). In contrast, the absence of NF-L
extended the average life span of SOD1G37R mice by z10abnormally hyperphosphorylated in the SOD1G37R mice.
In normal mice, insignificant perikaryal staining occurs weeks. These studies with various SOD1G37R mouse lines
having NF abnormalities suggested beneficial effectswith the SMI 31 and NN 18 antibodies that recognized
the hyperphosphorylated forms of NF-H and NF-M, re- of perikaryal accumulations of NF proteins in disease
caused by mutant SOD1.spectively (Figure 2E, two upper panels). In contrast, in
SOD1G37R mice, a robust immunostaining of neuronal Because NF-M and NF-H proteins are major Cdk5
substrates with multiple phosphorylation sites, weperikarya was obtained in cell body of motor neurons,
demonstrating the abnormal hyperphosphorylation of thought that perikaryal NF accumulations could confer
protection by acting as a phosphorylation sink for dereg-NF-H and NF-M proteins (Figure 2E, two lower panels).
ulated Cdk5 activity. Here, we present many lines of
evidence that support this model. First, perikaryal NFAlleviation of Disease by Perikaryal
inclusions in SOD1G37R mice were detected with antibod-Accumulations of NF Proteins
ies against hyperphosphorylated NF proteins and thatWe reported previously that overexpression of human
Cdk5 complexes colocalize with these inclusions. Sec-NF-H (hNF-H), a protein containing 34 consensus phos-
ond, the occurrence of perikaryal NF accumulations inphorylation sites for Cdk5, extended substantially the
SOD1G37R mice was found to be associated with reducedlife span of SOD1G37R mice (line 29). Remarkably, a more
phosphorylation of tau, another p25/Cdk5 substrate.efficient protection was conferred by the NF-H43 allele
Third, there is a correlation between the levels of Cdk5that produced more prominent NF accumulations in
activity and the longevity of mice expressing differentperikarya (Couillard-Despre´s et al., 1998). To investigate
amounts of mutant SOD1G37R. Moreover, the perikaryalfurther the effects of NF organization and distribution
NF accumulations were found to be less protective inon SOD1-mediated disease, we generated crosses be-
SOD1G37R mice that exhibit exceedingly high levels oftween SOD1G37R mice and mice in which the NF-H or
deregulated Cdk5 activity.NF-L gene had been deleted (respectively, G37R;H2/2
and G37R;L2/2 mice). This was done by breeding proce-
dures with previously described NF-H and NF-L knock- Cdk5 and p25 Colocalize with Perikaryal NF
Accumulations in SOD1G37R Miceout mice (Zhu et al., 1997; Zhu et al., 1998). The disrup-
tion of NF-H and NF-L genes in the SOD1G37R background As shown in Figures 3 and 4, the perikaryal NF accumula-
tions in mice expressing mutant SOD1 in NF-L knockoutproduced distinct morphological changes caused by
differences in NF protein levels and organization (Figure background or in hNF-H transgenic background are im-
munoreactive for antibodies recognizing phosphory-3B). Examination at light microscopy of the L5 ventral
root at presymptomatic stage (4 months old) showed lated NF proteins. Cdk5 was also immunodetected in
cytoplasmic accumulations of NF proteins in spinal mo-an hypotrophy of axons presumably due to NF scarcity
in the G37R;L2/2 mice, whereas no important changes tor neurons of 1-year-old SOD1G37R mice overexpressing
human NF-H (G37R;hNF-H) or lacking NF-L genein axonal caliber occurred in the G37R;H2/2 mice (Figure
3B). Moreover, the motor neurons of G37R;L2/2 exhib- (G37R;L2/2) (Figures 4A and 4B). Moreover, immuno-
staining with antibodies recognizing both p35 and p25ited perikaryal swellings caused by NF-H and NF-M
subunit accumulations, whereas motor neurons of (C-19) revealed a cytoplasmic and perinuclear staining
(Figure 4C). Such abnormal localization is likely the resultG37R;H2/2 had normal appearance (Figure 3B). Even
though the absence of NF-L provoked an z90% reduc- of p25 immunostaining because p35 is normally distrib-
uted in the membrane and nerve terminal (Nikolic et al.,tion of NF-H and NF-M protein levels in nervous tissue,
Neuron
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Figure 4. Colocalization of Cdk5 and p25 with Perikaryal Accumulations of NF Proteins in SOD1G37R Mice Overexpressing hNF-H or Lacking
NF-L
Cdk5 was immunodetected in perikaryal swellings, nucleus, and peripheral membranes of 1-year SOD1G37R mice overexpressing hNF-H44 (A,
white arrows) or lacking NF-L (B, white arrows). Mislocalization of the Cdk5 activator p25 in cytoplasmic and perinuclear regions of spinal
motor neurons from G37R;NF-H44, as revealed with C-19 antibody (C, white arrow). Double immunofluorescence experiments confirmed the
colocalization of p25/p35 and Cdk5 with perikaryal accumulations of NF proteins (Q9 to H † ), whereas p25/p35 and Cdk5 did not colocalize
with hyperphosphorylated NF-H in cell bodies of normal mice (D–O), hNF-H transgenic mice (P–X) and NF-L null mice (Y–G9). In G37R mice
with a wild-type NF background, the colocalization of Cdk5 and its activators with hyperphosphorylated NFs was sometimes observed (H9
to P9). For instance, (N9) to (P9) show the colocalization of p25 with some perikaryal phosphorylated NF-H. Immunofluorescence experiments
on (J) to (L) were performed with the N-20 antibodies that recognize specifically the N terminus of p35 but not p25, whereas p25/p35
immunoreactivities on (H), (I), (T), (U), (C9), (D9), (L9), (M9), (U9), (V9), (D† ), and (E† ) were obtained with the C-19 antibodies that recognize both
p25 and p35. (N), (O), (W), (X), (F9), (G9), (O9), (P9), (X9), (Y9), (G† ), and (H † ) were obtained with a p25-specific antibody. The NF-H protein was
detected with RT-97 and a secondary FITC-labeled antibody, whereas Cdk5, p25, and p35 were detected with a secondary Rhodamine-
labeled antibody. Bars: (A–C), 50 mm; (D–F, J–L, H9–P9), 7 mm; (G–I, M–O, P–R, V–X, Q9–V9, Z9–E† ), 20 mm; (S–U, Y–G9, W9–Y9, F† –H† ), 30 mm.
Deregulation of Cdk5 in ALS Pathogenesis
141
1996; Patrick et al., 1999). Moreover, p25 is an abundant
Cdk5 coactivator in the spinal cord of SOD1G37R mice
(Figures 1B, 1C, and 5C). Double immunofluorescence
microscopy confirmed the colocalization of Cdk5 and
its activators p25, p35 with perikaryal NF protein accu-
mulations in the G37R;hNF-H44 (Figures 4, panels Q9–Y9),
and G37R;L2/2 mice (Figures 4, panels Z 9–H† ).
Such colocalization of perikaryal NF proteins with
Cdk5/activators was not observed in spinal cord sec-
tions from normal mice (Figures 4D–4O), hNF-H trans-
genic mice (Figure 4P–4X) and NF-L null mice (Figure
4Y–4G9). In SOD1G37R mice with normal NF background,
the codetection of p25, p35, and Cdk5 with phosphory-
lated NF-H in neuronal cell bodies was sometimes ob-
served (Figure 4, panels H9–P9), but not to the same
extent as in SOD1G37R mice with perikaryal NF accumula-
tions (Figure 4 Q9–H† ). We estimated that z30% of motor
neurons in L5 spinal cord of SOD1G37R mice showed
perikaryal colocalization of p25/Cdk5 with phosphory-
lated NF-H. In contrast, the majority of spinal motor
neurons in G37R;L2/2 mice (z70%) and in G37R;hNF-H
mice (90%) showed colocalization of p25/Cdk5 with
phosphorylated NF-H in their perikaryon. Immunostain-
ing of spinal cord sections from the G37R;hNF-H or
G37R;L2/2 mice with antibodies against other kinases,
including MEK1/2, Erk1/2, JNK, p38, Gsk-3b, and p70S6K
did not show colocalization of these kinases with peri-
karyal NF inclusions (data not shown). The one excep-
tion was JNK that was found to localize to small-rounded
intracellular inclusions distinct from the perikaryal NF
inclusions in G37R, G37R;hNF-H, and G37R;L2/2 mice
(data not shown).
Following the method of graded centrifugation de-
scribed previously by Veeranna et al. (2000), we ana-
lyzed the distribution of NF, Cdk5, p25, and p35 proteins
in different pellets (P) and supernatants (S) (discussed
previously in this article). Briefly, protein extracts from
the spinal cord of normal and SOD1G37R mice were differ-
entially separated by centrifugation (P1 to P3, S1 to S3).
These extracts were then fractionated by SDS-PAGE
followed by immunoblotting using specific antibodies.
Figure 5A shows the levels and distribution of NF proteins
in fractions from SOD1G37R mice (G37R), G37R;hNF-H,
and G37R;L2/2 mice. Note that the G37R;L2/2 mice ex-
hibit a considerable reduction in levels of NF-M and NF-
H. In all mice, the NF proteins were recovered essentially
in P1, P2, and P3 fractions, whereas Cdk5 was recovered
in both P1 and S1 fractions. It is noteworthy that the
Figure 5. Distribution of NF, p25, p35 and Cdk5 Proteins in Spinal
Cdk5 levels in P1 of G37R;hNF-H and G37R;L2/2 miceCord Preparations
were 2- to 3-fold higher than those detected in P1 frac-(A) Western blots showing the distribution of NF proteins in pellet
tion of single SOD1G37R transgenic mice (Figure 5B), sug-1 (P1), P2, and P3 from SOD1G37R mice and SOD1G37R mice overex-
gesting enhanced interactions between Cdk5 and NFpressing hNF-H or lacking NF-L (G37R, G37R;hNF-H, G37R;L2/2).
Through centrifugation, the NF proteins were recovered mainly in proteins in SOD1G37R mice with perikaryal NF inclusions.
the P1, P2, and P3 fractions. The OC-95 antibodies recognize specif- Further support for the existence of interactions be-
ically the human hNF-H protein. Note the considerable decrease in tween Cdk5 and NF proteins was provided from immu-
levels of NF proteins from G37R;L2/2.
noprecipitation of Cdk5 with the C-8 antibodies. As(B) Increased levels of Cdk5 recovered in P1 of G37R;hNF-H and
G37R;L2/2 mice as compared with P1 of G37R mice.
(C) Recovery of p25 in the supernatant 1 (S1) fraction. This suggests
that p25 is not sequestered in perikaryal NF inclusions. These results
also show that neither overexpression of hNF-H nor lack of NF-L G37R;hNF-H mice but not in sample from G37R;H2/2 mice. Note
impeded cleavage of p35 to p25 in SOD1G37R mice. that SMI 31 cross-reacts with hyperphosphorylated NF-M in Cdk5
(D) Immunoprecipitation of cytoskeletal-enriched fraction from the immunoprecipitates from G37R;H2/2 mice. The membrane was
spinal cord with Cdk5 antibodies (C-8) pulls down phosphorylated stripped and reprobed with anti-Cdk5 antibodies for the to detection
NF-H (as detected by SMI 31 antibody) in samples from G37R and of Cdk5.
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shown in Figure 5D, the anti-Cdk5 antibodies pulled
down phosphorylated NF-H in spinal cord extracts from
SOD1G37R and G37R;hNF-H mice. Moreover, in extracts
from SOD1G37R mice lacking NF-H (G37R;H2/2), the anti-
Cdk5 antibodies immunoprecipitated hyperphosphory-
lated NF-M species, as detected with SMI 31 antibodies.
The cross-reactivity of SMI 31 with hyperphosphory-
lated NF-M is a phenomenon that was reported pre-
viously in NF-H null mice (Zhu et al., 1998).
The majority of p35 and p25 was recovered in the
soluble S1 fraction (Figure 5C). Note that the p25/p35
ratio in the H and S1 fractions from SOD1G37R mice (0.5 6
0.2) was identical to the ratio in samples from G37R;hNF-H
and G37R;L2/2 mice (0.5 6 0.1). Therefore, we conclude
that the protective effect of perikaryal NF inclusions in
SOD1G37R mice does not result from a decrease of p35
cleavage to p25.
Perikaryal NF Proteins Attenuates
Tau Phosphorylation
By immunoblotting, we have examined whether the oc-
currence of perikaryal NF inclusions in lines of SOD1G37R
mice resulted in a decrease in phosphorylation of tau,
another substrate of p25/Cdk5. As shown in Figure 6,
the AT-8 and PHF-1 immunoreactivities selective for
hyperphosphorylated tau were abolished in spinal cord
samples of SOD1G37R mice (10 to 12 months old) that
exhibited perikaryal accumulations of NF proteins, such
as in SOD1G37R mice bearing hNF-H43 or hNF-H44 trans-
genes (G37R;hNF-H43 or 44) and in SOD1G37R mice lacking
NF-L (G37R;L2/2). Conversely, the Tau 1 immunoreactiv-
ity for hypophosphorylated tau at a Cdk5 epitope was
considerably enhanced in spinal cord extracts from
these mice. Treatment of the membranes with alkaline
phosphatase abolished the AT-8 and PHF-1 immunore-
activities and restored the Tau 1 signal. These results
support the view that by acting as a phosphorylation
sink, perikaryal NF accumulations could interfere with
phosphorylation of other Cdk5 substrates. This model
of Cdk5-mediated pathogenesis is presented in Fig-
ure 8.
Correlation between Cdk5 Activity in SOD1G37R
Mice and Longevity
We thought that a correlation between Cdk5 activity and
severity of disease would provide further evidence for
(B) Attenuation of PHF-1 immunoreactivities in SOD1G37R mice with
perikaryal NF accumulations. Hyperphosphorylation of tau species
as indicated by increased PHF-1 immunoreactivities was observed
in spinal cord samples of SOD1G37R mice (lanes 3 and 4). There was
considerable reduction in PHF-1 signal in samples from SOD1G37R
Figure 6. Reduction of Tau Hyperphosphorylation at Cdk5 Sites in littermates exhibiting perikaryal accumulations of NF proteins (lanes
SOD1G37R Mice Exhibiting Perikaryal NF Accumulations 5–7).
(A) Western blots using the AT-8 monoclonal antibody indicate alle- (C) Restoration of Tau 1 immunoreactivity in SOD1G37R mice overex-
viation of tau phosphorylation by Cdk5 in SOD1G37R mice overex- pressing hNF-H transgenes or lacking NF-L. Hyperphosphorylation
pressing hNF-H transgenes or lacking NF-L. The hyperphosphoryla- of tau as reflected by reduced Tau 1 immunoreactivities occurred
tion of tau as indicated by AT-8 immunoreactivities was observed in spinal cord samples of SOD1G37R mice (lanes 3 and 4). The Tau
in spinal cord samples of SOD1G37R mice (G37R) (lanes 3 and 4) 1 signals were enhanced in SOD1G37R littermates with perikaryal
unlike normal mice (WT) (lanes 1and 2) and hNF-H transgenic mice accumulations of NF proteins (lanes 5–7). Treatment of membranes
(hNF-H) (lane 8). A considerable reduction in AT-8 signals was ob- with alkaline phosphatase abolished the AT-8 and PHF-1 signals
served in SOD1G37R littermates having perikaryal accumulations of and enhanced the Tau 1 signals in SOD1G37R mice, demonstrating
NF proteins, such as SOD1G37R mice coexpressing hNF-H43 (lane 5), that the signal intensities reflected the tau phosphorylation states
hNF-H44 (lane 6), or lacking NF-L (lane 7). rather than tau protein levels.
Deregulation of Cdk5 in ALS Pathogenesis
143
a Cdk5 involvement in ALS pathogenesis. Therefore, we
have compared the levels of Cdk5 activity in two lines
of SOD1G37R mice (lines 42 and 29) that exhibit different
life span (Figure 7 and Table 1). The SOD1G37R mice from
line 42 and 29, described previously by Wong et al.
(1995), overexpress the SOD1 transgene by z12-fold
and z5-fold, respectively. As shown in Figure 7, the
levels of Cdk5 activity in spinal cord extracts were more
elevated (2-fold) in mice from line 42 with a longevity of
z24 weeks than in those from line 29 with a life span
of z52 weeks.
To examine the effect of perikaryal NF accumulations
on the life span of mice with high levels of Cdk5 activity,
we generated doubly transgenic SOD1G37R; hNF-H43 by
crossing SOD1G37R mice of line 42 with hNF-H43 mice.
The survival curves in Figure 7 revealed that hNF-H over-
expression conferred little protection in SOD1G37R mice
of line 42. The hNF-H transgene slowed down disease
progression by z1 week in SOD1G37R mice from line 42,
whereas it extended the life span of mice from line 29
by z16 weeks (Figures 7A and 7C). These combined
results are consistent with a Cdk5 contribution to dis-
ease, and they suggest that exceedingly high levels of
Cdk5 activity could override the benefit of the NF phos-
phorylation sink.
Discussion
We report here that a deregulation of Cdk5 activity is
associated with disease caused by mutant SOD1. Our
results revealed a mislocalization of Cdk5 in the cyto-
plasm of motor neurons, an elevated ratio of p25 to
p35, and an increase of Cdk5 activity in SOD1G37R mice,
models of ALS. The deregulated Cdk5 activity in SOD1G37R
mice is accompanied by the hyperphosphorylation of
tau and NF proteins, as revealed by immunohistochem-
istry and immunoblots with various phospho-dependent
antibodies. A contribution of Cdk5 to neurodegeneration
is suggested from our finding of a correlation between
Cdk5 activity and longevity of ALS mice and from the Figure 7. Correlation Between Cdk5 Activity and Longevity of
slowing down of disease in SOD1G37R mice exhibiting SOD1G37R Mice
perikaryal accumulations of NF proteins. Because NF (A) Survival curves of SOD1G37R mice with a normal or altered NF
proteins are major Cdk5 substrates, we propose that background. The SOD1G37R mice (line 29) exhibiting perikaryal NF
inclusions as a result of NF-L knockout or overexpression of hNF-H43perikaryal NF accumulations may confer protection in
transgene had a lifespan of 10 to 16 weeks longer than SOD1G37RSOD1G37R mice by acting as a phosphorylation sink for
mice in normal NF background. The disruption of NF-H gene didderegulated Cdk5 activity, thereby reducing the noxious
not trigger formation of perikaryal NF inclusions, and it had no effect
hyperphosphorylation of other cellular substrates such on life span of SOD1G37R mice. The survival probability of transgenic
as tau (Figure 8). mice is plotted as a function of their age in weeks.
Several lines of evidence support this phosphorylation (B) Quantification of Cdk5 kinase activity in spinal cord extracts
from mice of line 29 overexpressing SOD1G37R by 5-fold or from micesink model. First, the perikaryal NF inclusions in SOD1G37R
of line 42 overexpressing SOD1G37R by 12-fold. The kinase assaysmice with hNF-H transgene or NF-L knockout back-
were performed after immunoprecipitation of extracts with Cdk5grounds were detectable with antibodies against hyper-
antibodies. The levels of Cdk5 activity were higher in SOD1G37R mice
phosphorylated NF proteins. Second, immunofluores- of line 42 that have a shorter life span. The autoradiogram shows
cence data revealed a colocalization of Cdk5/activator the quantity of 32P incorporated in histone H1 from Cdk5 in spinal
complexes with these perikaryal NF inclusions. The re- cord extracts of normal and SOD1G37R mice (lines 29 and 42) (upper
panel) and the levels of Cdk5 immunoprecipitated (lower panel). Allcovery of a small fraction of Cdk5 with NFs in P1 and
kinase assays were carried out using 10-month-old SOD1G37R micethe coimmunoprecipitation of NF-H with Cdk5 also sup-
(line 29) and 5-month-old SOD1G37R mice (line 42).port the view that NF aggregates can interact with Cdk5.
(C) Survival curves of mice from line 42 expressing SOD1G37R in a
Third, SOD1G37R mice with perikaryal NF accumulations normal NF background or in a hNF-H43 transgene background. The
showed reduction in hyperphosphorylation of tau at hNF-H overexpression slowed down disease by only 1 week in
Cdk5 sites, as judged by immunoblotting with three spe- SOD1G37R of line 42, suggesting that exceedingly high levels of Cdk5
could override the protective effect of perikaryal NF inclusions.cific antibodies: AT-8, PHF-1, and Tau 1. Fourth, the
hNF-H transgene overexpression conferred less protec-
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and progressive supranuclear palsy. Recent studies
with transgenic mice overexpressing the shortest hu-
man tau isoform demonstrated that neurodegenerative
disease can result from tau abnormalities (Ishihara et
al., 1999). In addition, the hyperphosphorylation of tau
by overexpression of the Cdk5 activator p25 was shown
to impair the microtubule-stabilizing function of tau re-
sulting into disruption of the neuronal cytoskeleton (Pat-
rick et al., 1999; Ahlijanian et al., 2000). It should be
noted that we did not detect filamentous tau aggregates
in SOD1G37R mice. Nevertheless, the hyperphosphoryla-
tion of tau can reduce its affinity for microtubules re-
sulting in their destabilization. A loss of microtubules
can impair axonal transport. Indeed, a slowing of axonal
Figure 8. Mechanism of ALS Pathogenesis Due to Deregulated transport has been reported in motor neurons of trans-
Cdk5 Activity and Protection by Perikaryal NF Inclusions genic mice expressing SOD1 mutants (Zhang et al.,
As a result of changes in calcium homeostasis, the p35 activator 1997; Williamson and Cleveland, 1999).
can be cleaved by calpain to yield p25 that lacks the myristoylation While recent studies suggest that a deregulation of
signal. The mislocalization and deregulation of Cdk5 by p25 promote
Cdk5 activity can induce cytoskeletal abnormalities andthe hyperphosphorylation of tau with ensuing neurodegeneration.
neuronal death (Patrick et al., 1999; Ahlijanian et al.,The perikayal NF accumulations act as a phosphorylation sink, and
2000), more experiments will be needed to determinethey sequester a fraction of Cdk5, thereby alleviating the noxious
hyperphosphorylation of tau and other substrates. exactly the degree to which Cdk5 contributes to ALS
pathogenesis and to establish the NF phosphorylation
sink model. For instance, transfection studies with p25/
Cdk5 cDNAs in cultured motor neurons would be usefultion in SOD1G37R mice (line 42) that exhibit very high levels
to confirm further the protective effects of perikaryal NFof Cdk5 activity and early disease onset, suggesting
accumulations and to show that excess Cdk5 activitythat excess Cdk5 activity could override the NF phos-
can override this protection. So far, this approach hasphorylation sink. The use of SOD1G37R mouse lines with
been hampered by the absence of perikaryal NF inclu-early-disease onset could explain why no effects on
sions in cultured motor neurons derived from hNF-Hdisease progression have been observed with a NF-H-
transgenic mice. Thus, more work is required to setlacZ transgene that induced large perikaryal NF accu-
up appropriate in vitro culture cell systems. Additionalmulations (Eyer et al., 1998).
transgenic mouse studies, such as the generation ofIt is noteworthy that the occurrence of perikaryal NF
mice expressing mutant SOD1 in backgrounds of p25inclusions did not affect the ratio of p25 to p35 in
overexpression, p35 knockout, or conditional Cdk5SOD1G37R mice (Figure 5). Two recent studies showed
knockout, would help to resolve fully the role of Cdk5an induction of p35 cleavage to p25 by the calcium-
activity in the neurodegenerative process. An alternativedependent protease calpain and its inhibition by calpain
approach of potential relevance for the development ofinhibitors (Kusakawa et al., 2000; Lee et al., 2000). The
therapy would be the testing of inhibitors of Cdk5 activityconversion of p35 to p25 in toxicity of mutant SOD1
for their ability to slow down disease in ALS mice.is compatible with the current view of altered calcium
homeostasis in ALS. A calcium involvement in ALS is
Experimental Proceduresstrongly supported by the selective vulnerability of mo-
tor neurons lacking typical calcium binding proteins, Generation and Genotyping of SOD1G37R Mouse Lines
parvalbumin, and calbindin (Ince et al., 1993; Elliot and Transgenic mice expressing SOD1G37R (lines 29 and 42; G37R) (Wong
et al., 1995), NF-H knockout (H2/2) mice (Zhu et al., 1998), NF-LSnider, 1995), as well as in a line of SOD1 transgenic
knockout mice (L2/2) (Zhu et al. 1997), and human NF-H43 an NF-H44mice (Morrison et al., 1996). Changes in intracellular
transgenic mice (lines 200 and 1398; hNF-H43 or 44 1/2) (Coˆte´ et al.,calcium could result from oxidative stress and particu-
1993; Couillard-Despre´s et al., 1998) have been generated as de-larly from mitochondrial damage reported in mutant
scribed previously and have been maintained on a pure C57BL6
SOD1 transgenic mice (Dal Canto and Gurney, 1995; background. G37R;H2/2 and G37R;L2/2 were obtained by breeding
Wong et al., 1995; Kong and Xu, 1998). Moreover, the respectively C57BL6 inbred G37R;H1/2 mice or G37R;L1/2 mice with
a littermate H1/2 or L1/2 mice to produce the G37R;H2/2 mice oroverexpression of the calcium binding protein calbindin
G37R;L2/2 mice. Inbred C57BL6 doubly transgenic G37R (lineD28K was recently reported to confer protection against
29);hNF-H43 or 441/2 and G37R (line 42);hNF-H431/2 were produced bymutant SOD1-mediated death of PC12 cells (Ghadge
breeding heterozygous G37R mice with heterozygous hNF-H43 or 44et al., 1997) and of cultured motor neurons expressing
mice. All animals were genotyped by Southern blotting. The life span
mutant SOD1G93A (Roy et al., 1998). of our SOD1G37R mouse (line 29) in a pure C57BL6 background is z52
Our findings of deregulated Cdk5 and tau hyperphos- weeks. The use of animals and all surgical procedures described in
this article were carried out according to The Guide to the Care andphorylation in motor neurons of SOD1G37R mice raises
Use of Experimental Animals of the Canadian Council on Animalup the possibility that tau abnormalities may contribute
Care.to ALS pathogenesis. The microtubule-associated pro-
tein tau has been implicated in the pathogenesis of neu-
Immunohistochemistry and Immunofluorescence Analysis
rodegenerative diseases, including Alzheimer’s disease Mice were sacrificed by overdose of chloral hydrate, perfused with
and diseases known as tauopathies such as fronto-tem- 0.9% NaCl, and then with fixative (3% v/v glutaraldehyde in phos-
phate-buffered saline [PBS] buffer [pH 7.4]). Tissues sections wereporal dementia, ALS/parkinsonism-dementia complex,
Deregulation of Cdk5 in ALS Pathogenesis
145
prepared for embedding in Epon as described by Zhu et al. (1997). and D. W. Cleveland for the kind gift of SOD1G37R mice (lines 29 and
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